Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Nefrologia ; 25(5): 515-20, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-16392301

RESUMO

OBJECTIVE: To evaluate the safety and effectiveness of the alfa-blocker doxazosin GITS in CRF patients. DESIGN AND METHODS: The study recruited 203 CRF patients (creatinine > 1,4 mg/dl for males, creatinine > 1,2 mg/dl for females, or creatinine clearance < 80 ml/min). All patients were receiving ACE inhibitores (63.4%) or angiotensin II antagonist (36.6%) therapy but they had higher blood pressure than recommended for CRF (130/85 mmHg). Patients were clinically evaluated 1, 3 and 6 moths after starting treatment with lercanidipine (10 mg once daily). Patients with high blood pressure in spite of combined therapy with two drugs added doxazosin GITS 4-8 mg once daily to treatment. RESULT: 57 patients rendered evaluable for the study (age 64.8 +/- 12.7 years, 47.4% males and 52.6 females). BP significantly decrease from 164 +/- 17/92 +/- 9 mmHg to 135 +/- 13/78 +/- 8 mmHg. 67.6% patients showed a significant BP reduction and 32.4% gets optimal BP control (< 130/85 mmHg). Two patients (3.6%) showed untoward effects. No biochemical changes were detected. CONCLUSIONS: Doxazosin showed a good antihypertensive effect in CRF patients when used as third drug in resistant severe hypertension. It has a good tolerability profile and showed a neutral profile on biochemical parameters.


Assuntos
Bloqueadores dos Canais de Cálcio/uso terapêutico , Doxazossina/uso terapêutico , Hipertensão/complicações , Hipertensão/tratamento farmacológico , Falência Renal Crônica/complicações , Falência Renal Crônica/tratamento farmacológico , Anti-Hipertensivos/uso terapêutico , Feminino , Humanos , Masculino
2.
Optom Vis Sci ; 70(1): 75-8, 1993 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8430011

RESUMO

Pigmented paravenous retinochoroidal atrophy is a rare disorder that is not well understood or classified. We examined a patient who had chorioretinal atrophy with pigment clusters located in the paravenous areas without macular involvement. Other conditions which may also present retinochoroidal atrophy and/or pigmentary degeneration are discussed. The electroretinography results were subnormal but the evoked potentials were not totally extinguished. Fluorescein angiography and retinography confirmed the relative and absolute scotomas corresponding to the atrophic paravenous areas.


Assuntos
Corioide/patologia , Epitélio Pigmentado Ocular/patologia , Retina/patologia , Veia Retiniana/patologia , Idoso , Atrofia , Eletrorretinografia , Potenciais Evocados Visuais , Feminino , Angiofluoresceinografia , Fundo de Olho , Humanos , Doenças Retinianas/patologia , Testes de Campo Visual , Campos Visuais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...